US EditionReturning UnitedHealth CEO to Face Questions over Pay and Share Price
- UnitedHealth faced turmoil after insurance leader Brian Thompson was killed execution-style in Manhattan in December 2024.
- The killing triggered shareholder lawsuits and a Justice Department probe into possible Medicare fraud, while Luigi Mangione pleaded not guilty to the murder.
- Following a 22% stock drop wiping out $119 billion in market value, the company cut its 2025 adjusted earnings forecast from $29.50–$30 to $26–$26.50 per share.
- Stephen J. Hemsley, who took over as CEO from Andrew Witty in mid-2025, expressed regret for recent difficulties and emphasized management’s commitment to restore investor trust and confidence.
- UnitedHealth plans independent reviews and likely will reduce Medicare Advantage benefits to address financial and operational challenges amid ongoing investigations.
11 Articles
11 Articles
Hastings Tribune
American Military NewsIn first speech back, UnitedHealth’s new CEO pledges to review hot-button issues
Newly back in the CEO chair at UnitedHealth Group, Stephen Hemsley on Monday vowed to address a series of lightning-rod issues that have heightened public scrutiny of the company.
UnitedHealth investors approve new CEO’s $60M pay package despite turmoil following top executive’s assassination
UnitedHealth investors approved a pay package for the returning chief executive that includes a $60 million stock option – even as the firm is plagued by financial losses, investigations and the shocking murder of its top insurance executive.
UnitedHealth plans to earn back shareholder trust, CEO says
NEW YORK (Reuters) -UnitedHealth Group’s new CEO Steve Hemsley on Monday apologized for the company’s recent earnings underperformance, and vowed it will curb rising costs in its insurance business and optimize quality in its health services moving forward. “We are well aware we have not fulfilled your expectations or our own. We apologize for that performance, and we’re humbly determined to earn back your trust and your confidence,” Hemsley sai…
Analysis: The No Good, Very Bad Year for UnitedHealth
UnitedHealth Group has had a difficult year marked by a dramatic stock drop, leadership shake-up and mounting regulatory scrutiny. Experts point to its aggressive Medicare Advantage strategy and a rapidly evolving healthcare landscape as key drivers of its challenges. The post Analysis: The No Good, Very Bad Year for UnitedHealth appeared first on MedCity News.
Coverage Details
Bias Distribution
- 57% of the sources are Center
To view factuality data please Upgrade to Premium
